2BC Innovations, LLC

A method executed by a computing device includes determining to enhance a legacy asset base, determining an asset selection approach, and selecting a subset of augmenting assets to produce selected augmenting assets. The method further includes splitting each of the selected augmenting assets by reassigning a future time-estimated benefit payment of each selected augmenting asset to a benefit entity and reassigning a series of time-certain obligated payments of each selected augmenting asset to a sponsor entity, such that a beneficial valuation elevation is created where a sum of a benefit net present value and a liability net present value is greater than a fair market value of the selected augmenting assets. The method further includes assigning a first portion of the benefit entity to the legacy asset base to leverage the beneficial valuation elevation over direct utilization of the selected augmenting assets.

A method executed by a computing device includes determining to enhance a legacy asset base, determining an asset selection approach, and selecting a first augmenting asset to produce a first selected augmenting asset of selected augmenting assets. The method further includes splitting the first selected augmenting asset by reassigning a future time-estimated benefit payment of the first selected augmenting asset to a benefit entity and reassigning a first series of time-certain obligated payments of the first selected augmenting asset to a sponsor entity, such that a beneficial valuation elevation is created where a sum of a benefit net present value and a liability net present value is greater than a fair market value of the selected augmenting assets. The method further includes assigning a portion of the benefit entity to a legacy asset base to leverage the beneficial valuation elevation over direct utilization of the selected augmenting assets.

A method executed by a computing device includes determining to enhance a legacy asset base, determining an asset selection approach, and selecting a subset of augmenting assets to produce selected augmenting assets. The method further includes splitting each of the selected augmenting assets to produce an augmenting asset bundle by reassigning a portion of a future time-estimated benefit payment of each selected augmenting asset to a benefit entity and reassigning a series of time-certain obligated payments of each selected augmenting asset to a sponsor entity, such that a beneficial valuation elevation is created where a sum of a benefit net present value and a liability net present value is greater than a fair market value of the selected augmenting assets. The method further includes assigning the benefit entity to the legacy asset base to leverage the beneficial valuation elevation over direct utilization of the selected augmenting assets.

A method executed by a computing device includes obtaining fulfillment information of a first longevity-contingent instrument of a set of longevity-contingent instruments. The method further includes verifying authenticity of an asset blockchain-encoded record representing sub-assets to produce an asset authenticity indicator and verifying authenticity of a liability blockchain-encoded record representing sub-liabilities to produce a liability authenticity indicator. When the asset authenticity indicator and the liability authenticity indicators are favorable, the method further includes facilitating exclusion of the first longevity-contingent instrument from the set of longevity-contingent instruments to produce updated sub-assets and updated sub-liabilities. The method further includes updating the asset blockchain-encoded record to represent the updated sub-assets and updating the liability blockchain-encoded record to represent the updated sub-liabilities.

A method executed by a computing device includes verifying authenticity of a blockchain-encoded record representing a longevity-contingent instrument of a set of longevity-contingent instruments to produce a verified blockchain-encoded record. When the longevity-contingent instrument is associated with an available and unfulfilled benefit status, the method further includes determining fulfillment information for the longevity-contingent instrument. The fulfillment information includes a benefit payout. The method further includes verifying authenticity of an asset blockchain-encoded record representing sub-assets and verifying authenticity of a liability blockchain-encoded record representing sub-liabilities. The method further includes facilitating exclusion of the longevity-contingent instrument from the set of longevity-contingent instruments to produce updated sub-assets and updated sub-liabilities. The method further includes updating the asset blockchain-encoded record to represent the updated sub-assets and updating the liability blockchain-encoded record to represent the updated sub-liabilities.

A method executed by a computing device includes determining an asset selection approach and selecting a first augmenting asset from available augmenting assets to produce a first selected augmenting asset of selected augmenting assets. The method further includes splitting the first selected augmenting asset by reassigning a portion of a future time-estimated benefit payment of the first selected augmenting asset to a benefit entity and reassigning a first series of time-certain obligated payments of the first selected augmenting asset to a sponsor entity, such that a beneficial valuation elevation is created where a sum of a benefit net present value and a liability net present value is greater than a fair market value of the selected augmenting assets. The method further includes assigning the benefit entity to a legacy asset base to leverage the beneficial valuation elevation over direct utilization of the selected augmenting assets.

A method executed by a computing device includes determining an asset selection approach for selecting a subset of available augmenting assets and selecting the subset of augmenting assets to produce selected augmenting assets. The method further includes splitting each of the selected augmenting assets to produce an augmenting asset bundle by reassigning a portion of a future time-estimated benefit payment of each selected augmenting asset to a benefit entity and reassigning a series of time-certain obligated payments of each selected augmenting asset to a sponsor entity, such that a beneficial valuation elevation is created where a sum of a benefit net present value and a liability net present value is greater than a fair market value of the selected augmenting assets. The method further includes assigning the benefit entity to a legacy asset base to leverage the beneficial valuation elevation over direct utilization of the selected augmenting assets.

A method executed by a computing device includes determining an asset selection approach and selecting a first augmenting asset from available augmenting assets to produce a first selected augmenting asset of selected augmenting assets. The method further includes splitting the first selected augmenting asset by reassigning a future time-estimated benefit payment of the first selected augmenting asset to a benefit entity and reassigning a first series of time-certain obligated payments of the first selected augmenting asset to a sponsor entity, such that a beneficial valuation elevation is created where a sum of a benefit net present value and a liability net present value is greater than a fair market value of the selected augmenting assets. The method further includes assigning a portion of the benefit entity to a legacy asset base to leverage the beneficial valuation elevation over direct utilization of the selected augmenting assets.

A method executed by a computing device includes determining an asset selection approach for selecting a subset of available augmenting assets and selecting the subset of augmenting assets to produce selected augmenting assets. The method further includes splitting each of the selected augmenting assets to produce an augmenting asset bundle by reassigning a future time-estimated benefit payment of each selected augmenting asset to a benefit entity and reassigning a series of time-certain obligated payments of each selected augmenting asset to a sponsor entity, such that a beneficial valuation elevation is created where a sum of a benefit net present value and a liability net present value is greater than a fair market value of the selected augmenting assets. The method further includes assigning a portion of the benefit entity to a legacy asset base to leverage the beneficial valuation elevation over direct utilization of the selected augmenting assets.

A method executed by a computing device includes verifying authenticity of an asset blockchain-encoded record representing sub-assets to produce an asset authenticity indicator and verifying authenticity of a liability blockchain-encoded record representing sub-liabilities to produce a liability authenticity indicator. When the asset authenticity indicator and the liability authenticity indicators are favorable, the method further includes riving another longevity-contingent instrument for inclusion in a set of longevity-contingent instruments to produce updated sub-assets and updated sub-liabilities. The method further includes updating the asset blockchain-encoded record to represent the updated sub-assets and updating the liability blockchain-encoded record to represent the updated sub-liabilities.